Genomictree Inc. (KOSDAQ:228760)
8,100.00
-600.00 (-6.90%)
Nov 20, 2026, 3:30 PM KST
Genomictree Market Cap
Genomictree has a market cap or net worth of 198.81 billion as of November 20, 2026. It is the 21,956th most valuable company in the world and the 764th biggest in South Korea. Its market cap has decreased by 66.90% in one year.
Market Cap
198.81B
Enterprise Value
119.97B
Revenue
2.95B
Global Rank
Country Rank
#764 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 198.81B, an increase of 236.98%. That is a compound annual growth rate of 13.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 198.81B | -69.85% |
| Dec 30, 2025 | 659.41B | 34.41% |
| Dec 30, 2024 | 490.60B | 0.78% |
| Dec 28, 2023 | 486.82B | 168.25% |
| Dec 29, 2022 | 181.48B | -32.87% |
| Dec 30, 2021 | 270.36B | -7.66% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDIPOST | 301.35B |
| Orum Therapeutics | 284.75B |
| SillaJen | 258.82B |
| Bioneer | 200.55B |
| GC Genome | 182.58B |
| GC Cell | 148.32B |
| Helixmith | 146.20B |
| NeoImmuneTech | 139.40B |